RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @ds_vault: Deep learning enables rapid identification of potent DDR1 kinase inhibitors - https://t.co/lvm9lfvBpX - #bigdata #deeplearni…
RT @biogerontology: Every year my group will try to get a tweet like that from Jason at least once. A cool experiment every year. https://t…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors - https://t.co/lvm9lfvBpX - #bigdata #deeplearning
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @biogerontology: Every year my group will try to get a tweet like that from Jason at least once. A cool experiment every year. https://t…
Every year my group will try to get a tweet like that from Jason at least once. A cool experiment every year.
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @AbcPharmacology: AIで46日で化合物最適化の話。これって標的変わったらどうなのか。そして納期が事前に予測できたのか、結果46日だったのか。利用する際の投資判断として気になる。 https://t.co/eFOoAkYKnq
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @InSilicoMeds: Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialI…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
wcs z2z
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7dZtvMt8eN
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
tretert
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
@RISEofTheFalen Posted... https://t.co/lTxHOoTvXh
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @pasanOnline: GANs used for drug discovery. Pretty cool stuff. https://t.co/yEcFZjedpE
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
💊A landmark article in #drug discovery published by @biogerontology on @NatureBiotech !
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Scientists used deep learning AI to discover and design new drug treatment for fibrosis, the results look very promising ⚕️ #biotech 🏷 #startup 🏷 #drugdiscovery 📰 Story details: https://t.co/b6rIFuvi8I 💡 Nature Biotechnology: https://t.co/grtHLvUDN2
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
Just what the doctor ordered. #AI can discover drugs faster -- and less expensively -- than current methods. https://t.co/pG30eGXUR0
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @biogerontology: Our paper surpassed 16K accesses at Nature Biotech. I wish I could make it Open Access https://t.co/cyafxr1ZK5
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @BenSingletonNYC: Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbg…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
This paper made a lot of noise last week in AI https://t.co/oeTMCJc9Vd
RT @ObiomaOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for pharm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DeepLearning #BigData https://t.co/9HbSbghlI2
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
GANs used for drug discovery. Pretty cool stuff.
This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordisk Paywalled unfortunately. https://t.co/QAjvqvdqpD
RT @theaaih: Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of pote…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7kZyxmjnBZ #DeepLearning
Perfect example of how the #AI field is advancing! https://t.co/z3mdSkB6ub Deep learning enables rapid identification of potent #DDR1 kinase inhibitors. #aiinhealthcare #AIML #AAIH